Literature DB >> 19138871

Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study.

Laura A Colangelo1, Brian Chiu, Peter Kopp, Kiang Liu, Susan M Gapstur.   

Abstract

OBJECTIVE: Animal and human studies suggest that C-reactive protein (CRP) may be inversely associated with serum insulin-like growth factor-I (IGF-I) concentrations. However, most human studies have not controlled adequately for confounding factors, particularly nutritional intake. This population-based study examined whether CRP is inversely associated with IGF-I and IGFBP-3 concentrations.
METHODS: In cross-sectional analysis, multivariable linear regression with adjustment for age, BMI, smoking status, alcohol intake, and nutritional factors was used to relate log CRP, the independent variable, to IGF-I and IGFBP-3 in a sample of black (n=364) and white men (n=486) separately by race.
RESULTS: Only black men had positive findings: log CRP was significantly associated with IGF-I (beta=-13.1 ng/ml, p=0.02) and the difference in mean IGF-I concentrations between the highest and lowest quartiles of CRP was 26 ng/ml. There was a statistically significant interaction between log CRP and smoking status (p=0.02); the regression coefficient for IGF-I predicted from log CRP was significant in smokers (beta=-39.8 ng/ml, p=0.0001), but not in non-smokers. The difference in mean IGF-I concentrations between highest and lowest quartiles of CRP was 100 ng/ml for black smokers. There were no associations for IGFBP-3.
CONCLUSIONS: In our study, CRP levels are inversely associated with IGF-I concentrations in black male smokers; however, the causal nature of the association is unclear and should be studied further.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138871      PMCID: PMC2798578          DOI: 10.1016/j.ghir.2008.12.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  62 in total

1.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.

Authors:  F De Benedetti; T Alonzi; A Moretta; D Lazzaro; P Costa; V Poli; A Martini; G Ciliberto; E Fattori
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.

Authors:  J P Thissen; J Verniers
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

Review 3.  Hormonal and nutritional regulation of IGF-I and its binding proteins.

Authors:  L E Underwood; J P Thissen; S Lemozy; J M Ketelslegers; D R Clemmons
Journal:  Horm Res       Date:  1994

Review 4.  The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrinol Metab Clin North Am       Date:  1996-09       Impact factor: 4.741

5.  Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products.

Authors:  Kaijun Niu; Atsushi Hozawa; Shinichi Kuriyama; Kaori Ohmori-Matsuda; Taichi Shimazu; Naoki Nakaya; Kazuki Fujita; Ichiro Tsuji; Ryoichi Nagatomi
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

6.  Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

Authors:  A G Thomas; J M Holly; F Taylor; V Miller
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

7.  Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease.

Authors:  B S Kirschner; M M Sutton
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

8.  The CARDIA dietary history: development, implementation, and evaluation.

Authors:  A McDonald; L Van Horn; M Slattery; J Hilner; C Bragg; B Caan; D Jacobs; K Liu; H Hubert; N Gernhofer; E Betz; D Havlik
Journal:  J Am Diet Assoc       Date:  1991-09

9.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

Authors:  L H Kuller; R P Tracy; J Shaten; E N Meilahn
Journal:  Am J Epidemiol       Date:  1996-09-15       Impact factor: 4.897

10.  Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.

Authors:  W J Smith; L E Underwood; D R Clemmons
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

View more
  5 in total

Review 1.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Authors:  Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren
Journal:  Pediatr Diabetes       Date:  2014-12-10       Impact factor: 4.866

3.  Insulin-like growth factor 1 opposes the effects of C-reactive protein on endothelial cell activation.

Authors:  Shao-Jun Liu; Yun Zhong; Xiang-Yu You; Wei-Hua Liu; Ai-Qun Li; Shi-Ming Liu
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

4.  Racial/Ethnic Differences in the Associations of Overall and Central Body Fatness with Circulating Hormones and Metabolic Factors in US Men.

Authors:  David S Lopez; Sabine Rohrmann; Sarah B Peskoe; Corinne E Joshu; Konstantinos K Tsilidis; Elizabeth Selvin; Adrian S Dobs; Norma Kanarek; Steven Canfield; William G Nelson; Elizabeth A Platz
Journal:  Int J Endocrinol Metab       Date:  2017-04-22

5.  Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Maria Ebbesen; Christian Enevold; Anders Juul; Carsten Heilmann; Henrik Sengeløv; Klaus Müller
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.